312 related articles for article (PubMed ID: 24468257)
1. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial.
Riedl MA; Bernstein JA; Li H; Reshef A; Lumry W; Moldovan D; Farkas H; Levy R; Baker J; Hardiman Y; Totoritis MC; Relan A; Cicardi M;
Ann Allergy Asthma Immunol; 2014 Feb; 112(2):163-169.e1. PubMed ID: 24468257
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks.
Li HH; Moldovan D; Bernstein JA; Reshef A; Porebski G; Stobiecki M; Baker J; Levy R; Relan A; Riedl M
J Allergy Clin Immunol Pract; 2015; 3(3):417-23. PubMed ID: 25680925
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study.
Riedl MA; Levy RJ; Suez D; Lockey RF; Baker JW; Relan A; Zuraw BL
Ann Allergy Asthma Immunol; 2013 Apr; 110(4):295-9. PubMed ID: 23535096
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.
Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Relan A; Visscher S; Haase G; Kaufman L; Hack CE
J Allergy Clin Immunol; 2010 Oct; 126(4):821-827.e14. PubMed ID: 20920772
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of peripheral attacks in hereditary angioedema patients.
Kusuma A; Relan A; Knulst AC; Moldovan D; Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Hack CE
Am J Med; 2012 Sep; 125(9):937.e17-24. PubMed ID: 22748405
[TBL] [Abstract][Full Text] [Related]
6. Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk.
Reshef A; Zanichelli A; Longhurst H; Relan A; Hack CE
Allergy; 2015 May; 70(5):506-13. PubMed ID: 25640891
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA
J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078
[TBL] [Abstract][Full Text] [Related]
8. A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema.
van Doorn MB; Burggraaf J; van Dam T; Eerenberg A; Levi M; Hack CE; Schoemaker RC; Cohen AF; Nuijens J
J Allergy Clin Immunol; 2005 Oct; 116(4):876-83. PubMed ID: 16210064
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
[TBL] [Abstract][Full Text] [Related]
10. Use of recombinant C1 inhibitor in patients with resistant or frequent attacks of hereditary or acquired angioedema.
Manson AL; Dempster J; Grigoriadou S; Buckland MS; Longhurst HJ
Eur J Dermatol; 2014; 24(1):28-34. PubMed ID: 24556385
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks.
Baker JW; Bernstein JA; Harper JR; Relan A; Riedl MA
Allergy Asthma Proc; 2018 Sep; 39(5):359-364. PubMed ID: 29954477
[TBL] [Abstract][Full Text] [Related]
12. Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks.
Bernstein JA; Relan A; Harper JR; Riedl M
Ann Allergy Asthma Immunol; 2017 Apr; 118(4):452-455. PubMed ID: 28284978
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks.
Li HH; Reshef A; Baker JW; Harper JR; Relan A
Allergy Asthma Proc; 2017 Nov; 38(6):456-461. PubMed ID: 28874235
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity assessment of recombinant human c1-inhibitor: an integrated analysis of clinical studies.
Hack CE; Mannesse M; Baboeram A; Oortwijn B; Relan A
BioDrugs; 2012 Oct; 26(5):303-13. PubMed ID: 22928662
[TBL] [Abstract][Full Text] [Related]
15. Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks.
Craig TJ; Rojavin MA; Machnig T; Keinecke HO; Bernstein JA
Ann Allergy Asthma Immunol; 2013 Sep; 111(3):211-5. PubMed ID: 23987198
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study.
Reshef A; Moldovan D; Obtulowicz K; Leibovich I; Mihaly E; Visscher S; Relan A
Allergy; 2013 Jan; 68(1):118-24. PubMed ID: 23121116
[TBL] [Abstract][Full Text] [Related]
17. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
Reshef A; Grivcheva-Panovska V; Kessel A; Kivity S; Klimaszewska-Rembiasz M; Moldovan D; Farkas H; Gutova V; Fritz S; Relan A; Giannetti B; Magerl M
Pediatr Allergy Immunol; 2019 Aug; 30(5):562-568. PubMed ID: 30993784
[TBL] [Abstract][Full Text] [Related]
19. Target levels of functional C1-inhibitor in hereditary angioedema.
Hack CE; Relan A; van Amersfoort ES; Cicardi M
Allergy; 2012 Jan; 67(1):123-30. PubMed ID: 21923668
[TBL] [Abstract][Full Text] [Related]
20. Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
Craig TJ; Bewtra AK; Hurewitz D; Levy R; Janss G; Jacobson KW; Packer F; Bernstein JA; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
Allergy Asthma Proc; 2012; 33(4):354-61. PubMed ID: 22856636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
